iFIT Cluster of Excellence Newsletter Vol. VIII
|
|
|
Dear members,
With our Email Newsletter, we want to keep you up to date with all new information surrounding our “Image-Guided and Functionally Instructed Tumor Therapies” Cluster of Excellence. Vol. VIII includes news, publications and general information from the past three months and upcoming events. The next newsletter will be published on September 1, 2025.
If you have any comments or feedback feel free to get in touch with us: ifitoffice@med.uni-tuebingen.de With best regards, iFIT Office Team |
|
|
| iFIT defends follow-up proposal in Bonn! |
|
|
| International Women and Girls Day in Science |
|
|
| Science Podcast with Juliane Walz |
|
|
| Multiscale Imaging Workshop
|
|
|
| International Women's Day
|
|
|
| Prof. Bernd Pichler receives ESMI Award |
|
|
| Prof. Juliane Walz receives prestigous award from Roche |
|
|
| Inês Paixão is our new iFIT Project Controller
|
|
|
| iFIT at the AACR 2025 in Chicago |
|
|
| Prof. Lars Zender at the EASL Congress in Amsterdam |
|
|
| Dr. Benjamin Ruf receives Jung Career Advancement Award |
|
|
| iFIT receives funding for second period! |
|
|
|
New iFIT Managing Director
|
|
|
|
New Assistant to the Executive Board
|
|
|
| Excellence Workshop Module II with Dr. Paul Charlton
3rd of June 2025
|
|
|
|
iFIT sponsors the NCII Novel Concepts in Innate Immunity Conference
10-13th of June 2025
|
|
|
|
Excellence Workshop Module III with Dr. Paul Charlton 24th of June 2025 |
|
|
| iFIT Lunch & Learn Session with Bettina Weigelin
2nd of July at 12:00pm (CEST)
Big lecture hall, Women's Clinic,
Calwer Straße 7
|
|
|
|
iFIT Seminar Series with Christoph Plass
7th of July 2025 at 12:00pm (CEST) Big lecture hall, Medical Clinic,
Otfried-Müller-Straße 10
|
|
|
|
iFIT Seminar Series with Benjamin Izar
30th of July 2025 at 12:00pm (CEST) |
|
|
First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer |
Rudalska, R., Harbig, J., Forster, M. et al. First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer. Nat Cancer 6, 259–277 (2025). https://doi.org/10.1038/s43018-024-00899-7 IF: 23.5 |
CLEC12A-directed immunocytokine with target cell-restricted IL-15 activity for treatment of acute myeloid leukemia |
Klimovich, B., Anton, L., Jung, J. et al. CLEC12A-directed immunocytokine with target cell-restricted IL-15 activity for treatment of acute myeloid leukemia. Frontiers in Immunology. Mar 27:16:1561823. (2025) 10.3389/fimmu.2025.1561823 IF: 5.7
|
A "Ligand First" Approach toward Selective, Covalent JNK2/3 Inhibitors |
Wydra, V., Plank, N., Zwirner, S. et al. A "Ligand First" Approach toward Selective, Covalent JNK2/3 Inhibitors. Journal of Medicinal Chemistry, May 22. (2025).
10.1021/acs.jmedchem.5c00884 IF: 7.1 |
Uncovering α-Selectivity for Liver X Receptor Agonists for Lipotoxic Cancer Therapies |
Pedreira, J., Woelffing, P., Schwarz, M. et al. Uncovering α-Selectivity for Liver X Receptor Agonists for Lipotoxic Cancer Therapies. Journal of Medicinal Chemistry,
Apr 10;68(7):7180-7196. (2025) 10.1021/acs.jmedchem.4c02712 IF: 7.1
| Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer |
Deng, S., Kim, W., Cheng, K., et al. Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer. Cancer & Metabolism, May 13;13(1):21 (2025) 10.1186/s40170-025-00391-5 IF: 6.0
|
|
|
Assistance to the Head of Research (f/m/d)
|
University Hospital of Tuebingen - Medical Clinic, CCU Translational Immunology
|
PhD student (f/m/d) in Natural Sciences |
University Hospital of Tuebingen - Medical Clinic, CCU Translational Immunology
|
|
|
Follow us on social media
|
Legal Notice
Cluster of Excellence “Image-Guided and Functionally Instructed Tumor Therapies” (iFIT)
Röntgenweg 11
72076 Tübingen, Germany Contact:
Public Relations
Steven Pohl Mail: steven.patrick.pohl@med.uni-tuebingen.de Click here to unsubscribe
|
|
|
|
